Strong Revenue and Growth Metrics
Total revenue of $186 million, a 27% increase year-over-year. Surgical revenue grew by 29%, significantly outpacing the market.
Record Adjusted EBITDA
$23 million in adjusted EBITDA, marking the fifth consecutive quarter of positive adjusted EBITDA and a 4x improvement over the same quarter last year.
Positive Cash Flow Generation
The company generated $5 million in free cash flow, reflecting improved asset management and infrastructure investments.
Surgeon User Growth
Surgeon user growth increased by 21%, reflecting strong adoption of ATEC's portfolio.
Market Position and Share
ATEC has become the third largest spine player in the U.S. market.
Expansion in Clinical Offerings
New product launches, including a cervical retractor system and segmental cervical plating system, expanding the procedural offering.
Increased Full Year Revenue Guidance
Full year revenue guidance increased by $8 million to $742 million, highlighting confidence in continued growth.